Insulin sensitization early after menarche prevents progression from precocious pubarche to polycystic ovary syndrome.
about
Prenatal exposure to low levels of androgen accelerates female puberty onset and reproductive senescence in miceTherapeutic strategies for ovulation induction in infertile women with polycystic ovary syndrome.A single nucleotide polymorphism in STK11 influences insulin sensitivity and metformin efficacy in hyperinsulinemic girls with androgen excess.Latin American consensus: children born small for gestational age.Interventional studies for polycystic ovarian syndrome in children and adolescents.Reproductive neuroendocrine dysfunction in polycystic ovary syndrome: insight from animal modelsIGF2/H19 hypomethylation in a patient with very low birthweight, preocious pubarche and insulin resistance.Prenatal hyperandrogenization induces metabolic and endocrine alterations which depend on the levels of testosterone exposure.Approach to the girl with early onset of pubic hair.Polycystic ovary syndrome in the pediatric populationState of the Art Review: Emerging Therapies: The Use of Insulin Sensitizers in the Treatment of Adolescents with Polycystic Ovary Syndrome (PCOS).Acquired non-type 1 diabetes in childhood: subtypes, diagnosis, and management.Precocious pubarche is associated with SGA, prematurity, weight gain, and obesity.Unlicensed use of metformin in children and adolescents in the UK.Recent advances in the treatment of polycystic ovary syndrome.Low-dose flutamide-metformin therapy for hyperinsulinemic hyperandrogenism in non-obese adolescents and women.The impact of obesity on female reproductive function.Pubertal development in girls born small for gestational age.Clinical features, investigations and management of adolescents with polycystic ovary syndromeMetabolic and reproductive features before and during puberty in daughters of women with polycystic ovary syndrome.Endocrinology and gynecology of girls and women with low birth weight.Optimal management of polycystic ovary syndrome in adolescence.Adolescence and polycystic ovary syndrome: current concepts on diagnosis and treatment.What does a diagnostic label of 'polycystic ovary syndrome' really mean in adolescence? A review of current practice recommendations.Absence of hepatotoxicity after long-term, low-dose flutamide in hyperandrogenic girls and young women.Fatty acid-binding protein-4 plasma levels are associated to metabolic abnormalities and response to therapy in girls and young women with androgen excess.Metformin-diet ameliorates coronary heart disease risk factors and facilitates resumption of regular menses in adolescents with polycystic ovary syndrome.Impact of metformin, oral contraceptives, and lifestyle modification on polycystic ovary syndrome in obese adolescent women: do we need a new drug?The evaluation and treatment of hirsute women.Functional ovarian hyperandrogenism and polycystic ovary syndrome in prepubertal girls with obesity and/or premature pubarche.High neutrophil count in girls and women with hyperinsulinaemic hyperandrogenism: normalization with metformin and flutamide overcomes the aggravation by oral contraception.Hyperandrogenism and excess weight gain.Pregnancy-related outcomes for women with polycystic ovary syndrome.
P2860
Q30417384-B4EA208F-D723-41D1-8FA3-79E5155CAA46Q33230782-A02033EB-8C59-4984-A610-101ED079B3F1Q33932744-3D110373-9CBC-4481-9785-F0FF61C4E8C4Q33965524-3E9D002D-A1A8-47B7-B6D0-2E82F6ECAB00Q33996662-A0F8A43B-1751-40AD-AD00-DD413082F834Q34244204-294F22C8-80AA-49B5-869F-97178B887602Q34285924-388BAE82-8A06-4BFE-B6D6-A4992A1D7B34Q34289032-14153F61-E312-40B4-8DD0-8D4556D5DD9DQ35001879-D87A0CAC-3541-4716-95AA-88051AA999ADQ35075035-A0221270-EAC7-49D1-ABEB-2F86E6DCAF7AQ35233754-FD477532-1C10-4A58-9486-A1B190533F80Q35277941-A87B0F7D-48C8-4715-A9BD-8B19619F075FQ35282753-DFEB0250-AA01-4325-9A4C-DE84F9E2E50FQ35640486-5D71A9EE-44BF-4053-8DE2-16E15FA465F4Q35906966-CED0126B-4CCC-49A7-969B-25E8C6ACD969Q36366167-D4BC9DA9-8BE8-4E85-9F7A-1150193548EBQ36941978-C0DF5F1D-90EF-4D1B-9375-AF308EF1EFB6Q37186541-1DFEFEDC-AC96-45E2-8E58-9B33EC9BB25AQ37294042-BAE20F54-96D9-491F-9FAF-77BAA8F98004Q37314250-12AEEF51-7ABA-4867-BE96-A8298965BEB8Q37949240-6BF11CEB-80A3-4EC4-9BB1-01744C27C340Q38535106-9610A7AE-0856-4642-89B2-ED73A4BF9F40Q38569694-B34B0FE1-1EB0-4D7C-8E15-A91A9B303FB8Q38633475-08A0B1F6-35D5-4E0B-AF2F-996867B90749Q40433879-8359F5D4-7667-4AEF-836B-C320D27ED9BEQ42488837-2855454C-3005-4481-9716-B973F8C7E0CBQ43229974-8444FED4-44DE-4F05-8573-F64D72EABF22Q43243485-60149E30-5FA9-4FC8-BD8A-7F6E7663263CQ43267068-341E56AF-86AB-4CAA-84EA-9EF55EDA833EQ43418211-1D7F2362-39FE-419E-9BBB-C08F2C3A12F9Q46499691-760F6A19-2307-4B70-8EDD-23B9078B58F5Q47354477-38F25FCB-330C-4730-BF4F-6B1EC80E2B65Q49959431-6C5E2344-D255-4935-88C2-CFD8DE6D9763
P2860
Insulin sensitization early after menarche prevents progression from precocious pubarche to polycystic ovary syndrome.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年学术文章
@wuu
2004年学术文章
@zh-cn
2004年学术文章
@zh-hans
2004年学术文章
@zh-my
2004年学术文章
@zh-sg
2004年學術文章
@yue
2004年學術文章
@zh
2004年學術文章
@zh-hant
name
Insulin sensitization early af ...... to polycystic ovary syndrome.
@en
Insulin sensitization early af ...... to polycystic ovary syndrome.
@nl
type
label
Insulin sensitization early af ...... to polycystic ovary syndrome.
@en
Insulin sensitization early af ...... to polycystic ovary syndrome.
@nl
prefLabel
Insulin sensitization early af ...... to polycystic ovary syndrome.
@en
Insulin sensitization early af ...... to polycystic ovary syndrome.
@nl
P2093
P1476
Insulin sensitization early af ...... to polycystic ovary syndrome.
@en
P2093
Angela Ferrer
Francis de Zegher
Lourdes Ibáñez
Rakesh Amin
P356
10.1016/J.JPEDS.2003.08.015
P407
P577
2004-01-01T00:00:00Z